Potential importance of dihydropyrimidine dehydrogenase (DPD) in cancer chemotherapy.
Milano
G
G
Centre Antoine-Lacassagne, Nice, France.
Etienne
M C
MC
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000493:pharmacokinetics*; D042943:Dihydrouracil Dehydrogenase (NADP); D005260:Female; D005472:Fluorouracil / Q000009:adverse effects / Q000493:pharmacokinetics; D005828:Genetics, Population; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology* / Q000235:genetics; D010088:Oxidoreductases / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D011686:Purine-Pyrimidine Metabolism, Inborn Errors / Q000201:enzymology / Q000235:genetics
D000970:Antineoplastic Agents; D010088:Oxidoreductases; D042943:Dihydrouracil Dehydrogenase (NADP); D005472:Fluorouracil